Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-03

Clinical Trial Update: Tricuspid Regurgitation Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial studying tricuspid regurgitation and related ventricular dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Tricuspid Regurgitation, Right Ventricular Dysfunction | Phase 4 | Status: COMPLETED